Likes Subject
Ok , here you go For Friday 10.14.22 Timing101 10/14/22 4:42 PM
What the Hell is wrong with this thing? Dusty18 10/10/22 11:22 AM
Post of the YEAR! Great work! pumper_stumper 03/24/22 8:15 AM
Joesph Cotropia has the ideal background to be pumper_stumper 02/23/22 5:03 PM
NEWS--> Enzolytics Inc. and Samsung Biologics Announce Development DOGONE 10/07/21 8:22 AM
Very positive Video. More potential partnership and/or licensing archilles 05/23/21 5:32 PM
Drama… “THERE IS DILUTION COMING. . . “ outlook2020 4 minutes ago
THERE IS DILUTION COMING. . . Finance8783 5 minutes ago
I agree, That would be my guess as well. outlook2020 6 minutes ago
Listening to opinions presented as fact is never outlook2020 6 minutes ago
WC What's in it this 2business 15 minutes ago
I dont think the Stump invests in anything,
Bullish
Bullish
WilsonCombat 20 minutes ago
Specifically what information is lacking? You obviously know Jim46 28 minutes ago
FTW SAYIN,verified..? WITH/CEO.. WHEN...FDA-approves.'pkg..TV..ADV'..Come,,'with..$.att 2business 49 minutes ago
Hey..now is this..you..ps..sure.,seems..lol ..and..many..if..thankful..+ 2business 1 hour ago
Timing you need to chime in today...got anything rockie101 1 hour ago
Tenacious posting - you make some valid points Jmach101 1 hour ago
I wouldn't get your hopes up rockie.... MAGA_PATRIOT 1 hour ago
The only folks who will buy it are mineanddine 1 hour ago
It's not even negative. It's constructive criticism, and
Bullish
Bullish
DRHUMI 1 hour ago
Onelavi lol mineanddine 1 hour ago
How much money does GSK have to put ENZC FTW 2 hours ago
Stumper is that you...lol
Bullish
Bullish
KPG1 2 hours ago
It doesn't matter what you or anyone here
Bullish
Bullish
DRHUMI 2 hours ago
Obviously ppl don't understand the FDA and the ENZC FTW 2 hours ago
Maybe Charles is going to play SANTA and rockie101 2 hours ago
Months after not delivering a product that the pumper_stumper 2 hours ago
Seems to be a misunderstanding of what a outlook2020 2 hours ago
The names obviously were omitted, doesnt negate the ENZC FTW 3 hours ago
LOL. Different rules eh? Which drugs pumper_stumper 3 hours ago
Mutat - You are 100% correct about that. MAGA_PATRIOT 3 hours ago
That's all I needed. Proof! THIS is pumper_stumper 3 hours ago
Yeah your right, this a 30-40 yr scam Tkmoney1 3 hours ago
Hmmm they are...working in Africa..diff..rules..approx..70%..cases..there 2business 3 hours ago
What does it matter and why would I Tkmoney1 3 hours ago
Thanks, and agreed Africa will be a huge Valuator2 3 hours ago
Invest in scams much? Show pumper_stumper 3 hours ago
Yes, that would be a good start!
Bullish
Bullish
Catpole 3 hours ago
Invest in bio-tech much? This is the way outlook2020 3 hours ago
Correct. I haven't been able to find much Tkmoney1 3 hours ago
Could add.. .J and J , Lilly to 2business 3 hours ago
Shouldn't investor that have done full due diligence pumper_stumper 4 hours ago
You are making this too easy! Repeatedly outlook2020 4 hours ago
So, that's Clone 3 you're referring to as Valuator2 4 hours ago
That would be nice, but our version now DRHUMI 4 hours ago
I don't have the exact date as I Tkmoney1 4 hours ago
Yes, and a perfect example before our eyes Catpole 4 hours ago
RXDX Catpole 4 hours ago
How long has it been since this drug pumper_stumper 4 hours ago
Most people invested in ENZC do KNOW what pumper_stumper 4 hours ago
They are currently doing efficacy testing in Europe Tkmoney1 4 hours ago
Not just that Mutat, but in the case Tkmoney1 4 hours ago
Most people don’t realize what happens to SP Mutat 4 hours ago
Ok, what ticker? DRHUMI 4 hours ago
They don't do what they say when they mineanddine 4 hours ago
Here is an example of what could happen Catpole 4 hours ago
Likes Subject

Timing101
10/14/22 4:42 PM
Dusty18
10/10/22 11:22 AM
pumper_stumper
03/24/22 8:15 AM
pumper_stumper
02/23/22 5:03 PM
Finance8783
5 minutes ago
outlook2020
6 minutes ago
2business
15 minutes ago
WilsonCombat
20 minutes ago
mineanddine
1 hour ago
mineanddine
1 hour ago
KPG1
2 hours ago
pumper_stumper
3 hours ago
MAGA_PATRIOT
3 hours ago
pumper_stumper
3 hours ago
pumper_stumper
3 hours ago
Catpole
3 hours ago
2business
3 hours ago
Tkmoney1
4 hours ago
Catpole
4 hours ago
pumper_stumper
4 hours ago
pumper_stumper
4 hours ago
DRHUMI
4 hours ago
mineanddine
4 hours ago

Enzolytics Inc (ENZC)

Followers
1217
Posters
Posts (Today)
74
Posts (Total)
166295
Created
01/07/10
Type
Free
Moderators DOGONE pumper_stumper Homebrew Bud-Wiser archilles foxi
P


http://enzolytics.com/











Enzolytics is forecasting $100 Billion of earnings (Profit) over 11 years from just the HIV drug they have developed.




Enzolytics has a technology platform will develop Monoclonal Antibodies (mAb) to target over 14 debilitating diseases, all of which offer of "the promise of total viral neutralization and as a result an effective CURE" - Charles Cotropia, CEO













Our Partners





I

Independent Valuation Report Pre Clinical Studies

 

HIV & AIDS INFO

Global HIV & AIDS statistics — 2019 fact sheet

Global HIV statistics

 

  • 24.5 million [21.6 million–25.5 million] people were accessing antiretroviral therapy (end ofJune 2019).
    37.9 million [32.7 million–44.0 million] people globally were living with HIV (end 2018).
    1.7 million [1.4 million–2.3 million] people became newly infected with HIV (end 2018).
    770 000 [570 000–1.1 million] people died from AIDS-related illnesses (end 2018).
    74.9 million [58.3 million–98.1 million] people have become infected with HIV since the start of the epidemic (end 2018).
    32.0 million [23.6 million–43.8 million] people have died from AIDS-related illnesses since the start of the epidemic (end 2018).

 

Investments

 

  • At the end of 2018, US$ 19.0 billion (constant 2016 dollars) was available for the AIDS response in low- and middle-income countries, almost 1 billion less than in 2017.
    • Around 56% of the total resources for HIV in low- and middle-income countries in 2018 were from domestic sources.

    UNAIDS estimates that US$ 26.2 billion (constant 2016 dollars) will be required for the AIDS response in 2020.

___________________________________________________________________________________



Press Release July 20-2021


Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.

for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies

https://www.creative-biolabs.com/

https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm

________________________________________



Press release July 21-2021


Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and

Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics


https://www.lonza.com/


https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar



_________________________________________



July 22 INTERVIEW


with
 
James Hicks, Charles Cotropia and Gurav Chandra



http://www.youtube.com/watch?v=mdljO9VLgj0




______________________________________________________________

 

     Press release July 29- 2021
 

Enzolytics Reports Its Progress Toward Completion Of Clinical Trials for Its ITV-1 ANTI-HIV Therapeutic and


Securing Use Authorization Under the European Medicines Agency



https://finance.yahoo.com/news/enzolytics-reports-progress-toward-completion-113000008.html


___________________________________________________________________________________





Aug 25 News Release


https://enzolytics.com/company-news/


 

Enzolytics Progress Update

COLLEGE STATION, TX August 25, 2021

Important Excerpt from this news progress update.
>>>>>><<<<<<

"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."


______________________________________________________________



MUST READ UPDATE
•••••• October 7th News Release ••••••


https://www.bloomberg.com/press-releases/2021-10-07/enzolytics-inc-and-samsung-biologics-announce-development-and-manufacturing-agreement-for-anti-hiv-and-anti-sars-cov-2


 

Enzolytics Inc. and Samsung Biologics Announce

Development and Manufacturing Agreement for Anti-

HIV and Anti-SARS-CoV-2




Important Excerpt from this news progress update.

>>>>>><<<<<<

 

    "Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."
_______



ENZOLYTICS ..Creating rABS (recombinate monoconal antibodies)   https://info.gbiosciences.com/blog/recombinant-antibodies-an-overview


to eat up HIV and COVID..!





Enzolytics Inc.

2000 North Central Expressway

Plano, TX 75074

972-292-9414

New Post